Beta blockers linked to reduced 1-Year mortality in critically ill congestive heart failure patients with differential benefits across subgroups
{{output}}
The efficacy of beta (β) blockers in critically ill patients with congestive heart failure (CHF) remains uncertain. This study investigated the association of β blockers use with 1-year all-cause mortality in these patients. Utilizing a retrospective cohort,... ...
